![Jeffrey Sklar](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jeffrey Sklar
Gründer bei Sklar Kirsh LLP
Aktive Positionen von Jeffrey Sklar
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Sklar, Heyman & Co. LLP
![]() Sklar, Heyman & Co. LLP Miscellaneous Commercial ServicesCommercial Services Sklar, Heyman & Co. LLP provides accounting services. The company is headquartered in Bellmore, NY. | Corporate Officer/Principal | 01.01.2006 | - |
SHC Consulting Group LLC | Corporate Officer/Principal | 01.01.2000 | - |
Sklar Kirsh LLP
![]() Sklar Kirsh LLP Miscellaneous Commercial ServicesCommercial Services Sklar Kirsh LLP provides legal services. The private company is based in Los Angeles, CA. The company was founded by Andrew T. Kirsh, Jeffrey Sklar. | Vorsitzender | - | - |
Gründer | - | - |
Karriereverlauf von Jeffrey Sklar
Ehemalige bekannte Positionen von Jeffrey Sklar
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Public Savings Bank | Direktor/Vorstandsmitglied | 01.09.2010 | 01.09.2011 |
HepaLife Technologies, Inc.
![]() HepaLife Technologies, Inc. Medical/Nursing ServicesHealth Services Alliqua, Inc. is a biomedical products company focused on the development and manufacturing of proprietary technologies in the fields of drug delivery, advanced wound care and liver health preservation. It intends to develop active ingredient and transdermal drug delivery products, primarily utilizing the proprietary hydrogel technology platform manufactured by its subsidiary AquaMed Technologies, Inc. The firm develops HepaMate, an extracorporeal cell-based bioartificial liver system designed to combine blood detoxification with liver cell therapy to provide whole liver function in patients with the most severe forms of liver failure. Its HepaMate is comprised of a blood plasma separation cartridge, a hollow-fiber bioreactor filled with proprietary porcine liver cells, a charcoal column, an oxygenator, circuit tubing and a plasma reservoir. The company was founded on October 21, 1997 and is headquartered in New York, NY. It changed its name from HepaLife Technologies, Inc. in January 2011. | Direktor/Vorstandsmitglied | 06.01.2011 | 06.01.2011 |
Alliqua BioMedical, Inc.
![]() Alliqua BioMedical, Inc. BiotechnologyHealth Technology Alliqua BioMedical, Inc. engages in commercializing differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue. Its commercial wound care portfolio consists of wound bed preparation and human biologics. It also manufactures custom electron beam cross-linked and aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was founded on October 27, 1997 and is headquartered in Langhorne, PA. | Direktor/Vorstandsmitglied | 03.01.2011 | - |
Independent Dir/Board Member | 03.01.2011 | - |
Statistik
International
Vereinigte Staaten | 7 |
Operativ
Director/Board Member | 3 |
Corporate Officer/Principal | 2 |
Independent Dir/Board Member | 1 |
Sektoral
Commercial Services | 3 |
Health Services | 2 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 6 |
---|---|
HepaLife Technologies, Inc.
![]() HepaLife Technologies, Inc. Medical/Nursing ServicesHealth Services Alliqua, Inc. is a biomedical products company focused on the development and manufacturing of proprietary technologies in the fields of drug delivery, advanced wound care and liver health preservation. It intends to develop active ingredient and transdermal drug delivery products, primarily utilizing the proprietary hydrogel technology platform manufactured by its subsidiary AquaMed Technologies, Inc. The firm develops HepaMate, an extracorporeal cell-based bioartificial liver system designed to combine blood detoxification with liver cell therapy to provide whole liver function in patients with the most severe forms of liver failure. Its HepaMate is comprised of a blood plasma separation cartridge, a hollow-fiber bioreactor filled with proprietary porcine liver cells, a charcoal column, an oxygenator, circuit tubing and a plasma reservoir. The company was founded on October 21, 1997 and is headquartered in New York, NY. It changed its name from HepaLife Technologies, Inc. in January 2011. | Health Services |
Public Savings Bank | Finance |
Sklar, Heyman & Co. LLP
![]() Sklar, Heyman & Co. LLP Miscellaneous Commercial ServicesCommercial Services Sklar, Heyman & Co. LLP provides accounting services. The company is headquartered in Bellmore, NY. | Commercial Services |
SHC Consulting Group LLC | |
Sklar Kirsh LLP
![]() Sklar Kirsh LLP Miscellaneous Commercial ServicesCommercial Services Sklar Kirsh LLP provides legal services. The private company is based in Los Angeles, CA. The company was founded by Andrew T. Kirsh, Jeffrey Sklar. | Commercial Services |
Alliqua BioMedical, Inc.
![]() Alliqua BioMedical, Inc. BiotechnologyHealth Technology Alliqua BioMedical, Inc. engages in commercializing differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue. Its commercial wound care portfolio consists of wound bed preparation and human biologics. It also manufactures custom electron beam cross-linked and aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was founded on October 27, 1997 and is headquartered in Langhorne, PA. | Health Technology |
- Börse
- Insiders
- Jeffrey Sklar
- Erfahrung